System | Type | Disorder | Pubmed |
cancer | digestive | stomach | |
RRM2 is a novel target for effective diagnosis and treatment of gastric cancer |
cancer | skin | | |
inhibition of RRM2 converts the transient response of melanoma cells to BRAF inhibitor to a stable response and may be a novel combinatorial strategy to prolong therapeutic response of melanoma patients |
cancer | reproductive | uterus | |
inhibition of RRM2 activity may be a novel therapeutic strategy for human cervical cancer |
cancer | digestive | colon | |
novel therapeutic target, thus highlighting the potential utility of RRM2 inhibitors in colorectal cancer with oncogenic KRAS |